Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy

Ophthalmology

Volumn 118, Issue 2, 2011, Pages 415-422

  Marmor, Michael F ^a   Kellner, Ulrich ^b,c   Lai, Timothy Y Y ^d   Lyons, Jonathan S ^e   Mieler, William F ^f  

^a STANFORD UNIVERSITY   (United States)

^b AugenZentrum Siegburg ^*  (Germany)

^c RetinalScience   (Germany)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e GEORGETOWN UNIVERSITY   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE;

ARTICLE; AUTOFLUORESCENCE; BODY HEIGHT; BODY WEIGHT; COUNSELING; DRUG OVERDOSE; DRUG SCREENING; ELECTRORETINOGRAPHY; HUMAN; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RETINA MACULOPATHY; RETINOPATHY; RISK ASSESSMENT; RISK FACTOR; SHORT STATURE; TOXICITY TESTING; VISUAL FIELD; VISUAL IMPAIRMENT;

ACADEMIES AND INSTITUTES; AGE FACTORS; ANTIRHEUMATIC AGENTS; CHLOROQUINE; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; ELECTRORETINOGRAPHY; FLUORESCEIN ANGIOGRAPHY; HUMANS; HYDROXYCHLOROQUINE; OPHTHALMOLOGY; RETINA; RETINAL DISEASES; RISK ASSESSMENT; TOMOGRAPHY, OPTICAL COHERENCE; UNITED STATES;

EID: 79551548116     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.11.017     Document Type: Article

References (23)

1. M. Easterbrook Long term case of antimalarial toxicity after cessation of treatment Can J Ophthalmol 27 1992 237 239
2. A. Elman, R. Gullberg, and E. Nilsson Chloroquine retinopathy in patients with rheumatoid arthritis Scand J Rheumatol 5 1976 161 166
3. M. Mavrikakis, S. Papazoglou, and P.P. Sfikakis Retinal toxicity in long term hydroxychloroquine treatment Ann Rheum Dis 55 1996 187 189
4. I. Mavrikakis, P.P. Sfikakis, and E. Mavrikakis The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal Ophthalmology 110 2003 1321 1326
5. M.F. Marmor, R.E. Carr, M. Easterbook American Academy of Ophthalmology Recommendations on screening for chloroquine and hydroxychloroquine retinopathy Ophthalmology 109 2002 1377 1382
6. T.Y. Lai, W.M. Chan, and H. Li Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy Am J Ophthalmol 140 2005 794 807
7. M. Elder, A.M. Rahman, and J. McLay Early paracentral visual field loss in patients taking hydroxychloroquine Arch Ophthalmol 124 2006 1729 1733
8. R.T. Tzekov, A. Serrato, and M.F. Marmor ERG findings in patients using hydroxychloroquine Doc Ophthalmol 10 2004 87 97
9. G.D. Levy, S.J. Munz, and J. Paschal Incidence of hydroxychloroquine retinopathy in a large multicenter outpatient practice Arthritis Rheum 40 1997 1482 1486
10. F. Wolfe, and M.F. Marmor Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus Arthritis Care Res (Hoboken) 62 2010 775 784
11. J.S. Lyons, and M.L. Severns Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography Am J Ophthalmol 143 2007 801 809
12. J.S. Lyons, and M.L. Severns Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review: Review of mfERG ring ratios in Plaquenil toxicity Doc Ophthalmol 118 2009 29 36
13. I. Ingster-Moati, M. Crochet, and E. Manchon Analysis of 925 patients on long-term hydroxychloroquine or chloroquine treatment: results of ophthalmological screening [in French] J Fr Ophtalmol 27 2004 367 373
14. N. Costedoat-Chalumeau, Z. Amoura, and J.S. Hulot Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus Arthritis Rheum 54 2006 3284 3290
15. N.F. Shroyer, R.A. Lewis, and J.R. Lupski Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? Am J Ophthalmol 131 2001 761 766
16. S. Kellner, S. Weinitz, and U. Kellner Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence Br J Ophthalmol 93 2009 1444 1447
17. T.Y. Lai, J.W. Ngai, and W.M. Chan Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy Doc Ophthalmol 112 2006 177 187
18. R.K. Maturi, M. Yu, and R.G. Weleber Multifocal electroretinographic evaluation of long-term hydroxychloroquine users Arch Ophthalmol 122 2004 973 981
19. Pasadhika S, Fishman GA. Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. 2010;24:3406. Epub 2009 Apr 17.
20. U. Kellner, A.B. Renner, and H. Tillack Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine Invest Ophthalmol Vis Sci 47 2006 3531 3538
21. J.A. Rodriguez-Padilla, T.R. Hedges III, and B. Monson High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy Arch Ophthalmol 125 2007 775 780 (Pubitemid 46919738)
22. K.E. Stepien, D.P. Han, and J. Schell Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss Trans Am Ophthalmol Soc 107 2009 28 34
23. American Academy of Ophthalmology Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern 2010 American Academy of Ophthalmology San Francisco www.aao.org/PPP Accessed December 9, 2010